Data as of .
BULD vs FMED: which is really different?
BULD and FMED hold 0% of their weight in the same names, and BULD returned more over the year.
ETFIQ Off-Index Score: BULD scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
0% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, BULD and FMED hold 0% of their money in the same securities at the same weight.
| Only in BULD | Only in FMED |
|---|---|
| ASML Holding NV 8.91% | UCB SA 4.75% |
| Proto Labs Inc 8.59% | LIFESTANCE HEALTH GROUP INC 4.29% |
| Lam Research Corp 8.44% | DANAHER CORP 3.43% |
| Applied Materials Inc 8.29% | 10X GENOMICS INC 3.12% |
| Stratasys Ltd 5.79% | INTUITIVE SURGICAL INC 2.93% |
| KLA Corp 5.53% | COGENT BIOSCIENCES INC 2.86% |
| Autodesk Inc 5.49% | ALNYLAM PHARMACEUTICALS INC 2.80% |
| 3D Systems Corp 4.82% | ARGENX SE 2.79% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and May 31, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| BULD | FMED | BULD | FMED | BULD | FMED | |
| 3 months | −7.2% | +21.3% | −9.5 pts | +19.0 pts | −4.8 pts | +23.7 pts |
| 6 months | +26.1% | +32.3% | +8.1 pts | +14.3 pts | +1.9 pts | +8.0 pts |
| 1 year | +37.2% | +28.3% | +20.6 pts | +11.7 pts | +15.4 pts | +6.5 pts |
| 3 years | +84.5% | +39.6% | +6.1 pts | −38.8 pts | −13.7 pts | −58.5 pts |
| Since launch | +75.7% | +25.8% | −19.8 pts | −57.6 pts | −60.9 pts | −78.1 pts |
| BULD Pacer BlueStar Engineering the Future ETF Holds 55 stocks in broad innovation and megatrends, 36% of its weight in S&P 500 companies | FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Pacer | Fidelity |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 35.8% | 25.4% |
| Active share vs the S&P 500 | 97.2% | 97.1% |
| In the Nasdaq-100 | 36.7% | 8.7% |
| Holdings | 55 | 68 |
| Top ten, share of the fund | 62.9% | 31.5% |
| Expense ratio | 0.49% | 0.50% |
| Fee for the differing part | 0.50% | 0.51% |
| Total return, 1 year | +37.2% | +28.3% |
| vs the S&P 500 | +20.6 pts | +11.7 pts |
| vs the Nasdaq-100 | +15.4 pts | +6.5 pts |
| Below its high | −10.4% | −3.8% |
| Net assets | $5m | $52m |
BULD in plain words
By weight, 36% of BULD's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 63% of the fund across 55 positions, as filed for Apr 30, 2026. Over the year to Sep 18, 2026 the fund returned +37.2% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 20.6 pts. It sits 10.4% below its all-time high of Jun 30, 2026.
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
Questions people ask
- Do BULD and FMED hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, BULD or FMED?
- BULD has 36% of its weight in S&P 500 names and FMED has 25%, so BULD differs more from the index.
- Which is cheaper, BULD or FMED?
- BULD charges 0.49% a year and FMED charges 0.50%, so BULD is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BULD against FMED, data as of Sep 18, 2026. https://etfiq.com/compare/themes/buld-vs-fmed Free to use with attribution; the underlying files are at Open data.